Nurix Therapeutics (NRIX) Shares Issued (2019 - 2025)
Historic Shares Issued for Nurix Therapeutics (NRIX) over the last 7 years, with Q4 2025 value amounting to $232.5 million.
- Nurix Therapeutics' Shares Issued rose 14843.27% to $232.5 million in Q4 2025 from the same period last year, while for Nov 2025 it was $234.8 million, marking a year-over-year increase of 2664.58%. This contributed to the annual value of $234.8 million for FY2025, which is 1898.14% down from last year.
- According to the latest figures from Q4 2025, Nurix Therapeutics' Shares Issued is $232.5 million, which was up 14843.27% from $977000.0 recorded in Q3 2025.
- Nurix Therapeutics' Shares Issued's 5-year high stood at $232.5 million during Q4 2025, with a 5-year trough of -$183000.0 in Q4 2022.
- Over the past 5 years, Nurix Therapeutics' median Shares Issued value was $1.3 million (recorded in 2025), while the average stood at $32.6 million.
- In the last 5 years, Nurix Therapeutics' Shares Issued tumbled by 13307.69% in 2021 and then skyrocketed by 531237.11% in 2024.
- Nurix Therapeutics' Shares Issued (Quarter) stood at -$43000.0 in 2021, then crashed by 325.58% to -$183000.0 in 2022, then skyrocketed by 524.04% to $776000.0 in 2023, then surged by 11961.86% to $93.6 million in 2024, then skyrocketed by 148.43% to $232.5 million in 2025.
- Its last three reported values are $232.5 million in Q4 2025, $977000.0 for Q3 2025, and $1.3 million during Q1 2025.